Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT04980859
Eligibility Criteria:
Inclusion Criteria:
* CLL patients with indications for treatment according to iwCLL;
* CT/MRI shows measurable lesions;
* ECOG score is 0-2;
* No pregnancy plans during treatment
Exclusion Criteria:
* Richter transformation;
* 17p-/TP53 amplification ≥20% (FISH);
* Received steroids within 7 days before starting treatment;
* Have previously received treatments for chronic lymphocytic leukemia;
* Vaccine live attenuated vaccine within 4 weeks of randomization;
* Any life-threatening disease;
* Central nervous system leukemia;
* Apoplexy, history of intracranial hemorrhage;
* HIV or HCV or HBVpositive
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04980859
Study Brief:
Protocol Section:
NCT04980859